GPBAR1 and rheumatoid arthritis: In rheumatoid arthritis models, probiotic-induced DCA/LCA activated TGR5 (likely Gs-cAMP mediated given the anti-inflammatory outcome) to suppress Th1/Th17 responses, an effect nullified by the TGR5 antagonist SBI-115 (79).